Onderneming Reviva Pharmaceuticals Holdings, Inc. Nasdaq
Aandelen
TZAC
US76152G1004
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 15
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 59 | 11-12-20 | |
Narayan Prabhu
DFI | Director of Finance/CFO | 53 | 14-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 69 | 14-12-20 | |
Les Funtleyder
BRD | Director/Board Member | 54 | 14-12-20 |
Founder | 59 | 11-12-20 | |
Purav Patel
BRD | Director/Board Member | 42 | 14-12-20 |
Richard Margolin
BRD | Director/Board Member | 73 | 14-12-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 29 817 294 | 24 872 459 ( 83,42 %) | 0 | 83,42 % |
Bedrijfsgegevens
Reviva Pharmaceuticals Holdings, Inc.
10080 North Wolfe Road Suite SW3-200
95014, Cupertino
+
http://www.revivapharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |